Shaowei Lan
Jilin Provincial Key Laboratory Of Molecular Diagnosis And Treatment For Malignant Tumor
Changchun, China
Changchun, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Application of organoid models in basic and translational research of lung cancer: a narrative review.
Journal: Translational lung cancer research
Published: January 14, 2026
The Promoting Angiogenesis and Its Clinical Significance of CD33+Myeloid Derived Suppressor Cells Derived From Small Cell Lung Cancer.
Journal: Chronic diseases and translational medicine
Published: September 17, 2025
A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2025
Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC.
Journal: Journal for immunotherapy of cancer
Published: November 05, 2024
Clinical application of minimal residual disease detection by ctDNA testing in non-small cell lung cancer: a narrative review.
Journal: Translational lung cancer research
Published: October 13, 2024
Precise identification of somatic and germline variants in the absence of matched normal samples.
Journal: Briefings in bioinformatics
Published: June 18, 2024
An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: a case report.
Journal: Translational lung cancer research
Published: October 13, 2023
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China.
Journal: Tumori
Published: June 20, 2022
Colony‑stimulating factor CSF2 mediates the phenotypic plasticity of small‑cell lung cancer by regulating the p‑STAT3/MYC pathway.
Journal: Oncology reports
Published: December 31, 2021
Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
Journal: Technology in cancer research & treatment
Published: December 01, 2021
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma.
Journal: OncoTargets and therapy
Published: August 26, 2020
Last Updated: 09/26/2026